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CardiomyocytesAccumulating evidence suggests that hypoxia-inducible factor 1a (HIF-1a) regulates numerous
miRNAs and is crucial for cellular response to hypoxia. However, the relationship between HIF-1a
and miR-21 in hypoxic cardiomyocytes is little known. We found that hypoxia induced HIF-1a
andmiR-21 expression. HIF-1a knockdown increased cell apoptosis and reduced miR-21 expression.
Furthermore, we found that HIF-1a transcriptionally enhanced miR-21 promoter activity by binding
to its promoter, which required the recruitment of CBP/p300. In addition, we found that miR-21
inhibition increased cell apoptosis and reduced HIF-1a expression, and modulated the PTEN/Akt
pathway. Our results indicate that HIF-1a-miR-21 feedback contributes to the adaptation of cardio-
myocytes to hypoxia, and has potential as therapeutic target for myocardial ischemia.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction by PHD is decreased, resulting in the HIF-1a activation [6]. As aIschemia tolerance initiated by preconditioning stimuli serves
as an endogenous defense strategy to protect cardiomyocytes
against ischemia and hypoxia injury. However, it cannot be widely
used in the clinic because of its potential impairment on the organ-
ism’s metabolic state [1]. Studies have shown that a great number
of molecular mediators participate in and improve the myocardial
ischemia and hypoxia [2]. Hypoxia-inducible factor-1 (HIF-1) is an
important regulator that play a vital role in response to low oxygen
(hypoxic condition) [3]. It is a heterodimeric transcription factor
consisting of a hypoxia-sensitive subunit HIF-1a and a constitu-
tively expressed b-subunit HIF-1b [4]. In normoxic condition,
HIF-1a is hydroxylated by PHD proteins, and subsequently
degraded via the recruitment of an ubiquitin-protein ligase VHL
[5]. Whereas in hypoxic condition, the hydroxylation of HIF-1atranscription factor, it regulates the expression of hundreds of
genes, including glucose transporter-4 (Glut-4) [7], vascular endo-
thelial growth factor (VEGF) [8], inducible nitric oxide synthase
(iNOS) [9] and heat shock protein 70 (HSP70) [10], which play cru-
cial role in the adaptation of response to hypoxia. Besides protein-
encoding genes, HIF-1a can activate the expression of numerous
miRNAs under hypoxia [11].miRNAs are a family of small non-cod-
ing RNA molecules that post-transcriptionally regulate gene
expression by binding to the sequences on the 30untranslated
region (30UTR) of the target genes through perfect or imperfect
complementarity, resulting in the target mRNA cleavage or trans-
lational repression [12–14]. Until now, approximately 60% of pro-
tein-coding genes is regulated by miRNAs [15], indicating that
they are involved in various biological processes, including cell
growth, apoptosis and differentiation [16]. miRNAs have been val-
idated to be aberrantly expressed in several diseases, such as
tumors [17,18]. Among the dysregulated miRNAs, miR-21 is one
of the well-known miRNAs and overexpressed in hepatocellular
carcinoma and breast cancer [19]. Besides in the initiation and pro-
gression of tumors, miR-21 has been identiﬁed to be involved in
response to hypoxia [20]. Maceetal. indicates that miR-21 is upreg-
ulated by HIF-1a under hypoxia in pancreatic cancer [21]. miR-21
is validated to contribute to angiogenesis via increasing HIF-1a
3138 Y. Liu et al. / FEBS Letters 588 (2014) 3137–3146expression [22]. However, little is known as to how the feedback
involving HIF-1a and miR-21 responses to the hypoxia in
cardiomyocytes.
In this study, we found that HIF-1a and miR-21 were induced
under hypoxic condition, as well as by CoCl2 treatment. HIF-1a
increased miR-21 expression by directly binding to the region of
miR-21 promoter. Silencing of HIF-1a and inhibition of miR-21
increased the apoptosis of hypoxic cardiomyocytes. Finally, our
results indicated that miR-21modulated PTEN and Bcl-2 expres-
sion, as well as the phosphorylation of Akt pathway.2. Materials and methods
2.1. Cell culture and culture conditions
Mouse cardiomyocytes, H9c2 and HL-1 cells, and human cardio-
myocytes HCM were cultured in Dulbecco’s Modiﬁed Eagle’s Med-
ium (DMEM, Gibco) supplemented with 10% (v/v) fetal bovine
serum (FBS) and 1% penicillin/streptomycin (100 U/ml and
100 lg/ml, respectively). All cells were grown in a humidiﬁed incu-
bator in a 5% CO2-humudiﬁed incubator at 37 C, which was
referred as normoxic conditions with 20%O2. For hypoxia H9c2,
HL-1 and HCM cells were seeded in 10 cm dish. After 24 h, the cells
were transferred to a modular incubator equipped with an O2 sen-
sor that regulated the mixing of N2 and air to give the desired levelFig. 1. HIF-1a and miR-21 are induced by hypoxia and CoCl2 treatment in cardiomyocyt
and 2% O2) conditions, or subjected to hypoxia mimetic conditions (CoCl2: 50 lM and
analyze the expression of HIF-1a. GAPDH served as a loading control. (B) qRT-PCR was
snRNA served as an internal control. Each value was the average of three independent eof hypoxia (10% O2 or 2% and 5% CO2 balanced with N2). Alterna-
tively, the hypoxic condition was chemically generated by treating
cells with 50 lM or 200 lM cobalt chloride (CoCl2, Sigma). For
hypoxia-reoxygen, cells under hypoxic conditions (2% O2 or
200 lM CoCl2) were transferred to the normoxic conditions and
the media was without CoCl2, respectively.
2.2. Western blotting
H9c2, HL-1 and HCM cells under normoxic or hypoxic condi-
tions were harvested and lysed with lysis buffer (50 mM
Tris–HCl, pH 8.8, 150 mM NaCl, 1% NP-40, 1% sodium deoxycho-
late, 0.1% SDS). Protein concentration was measured using BCA
method and subsequently 30 lg of proteins were separated on a
SDS–PAGE gel to analyze the expression levels of HIF-1a, HIF-1a
downstream effecters, and other proteins. GAPDH was used as a
loading control to normalize the protein levels. The primary anti-
bodies were mouse monoclonal to HIF-1a, mouse monoclonal to
CBP/p300, rabbit polyclonal to PTEN, rabbit polyclonal to Bcl-2,
rabbit polyclonal to AKT, rabbit polyclonal to phosphor-AKT, rabbit
polyclonal to GAPDH, rabbit polyclonal to Glucose Transporter
GLUT4, rabbit polyclonal to VEGFB, rabbit polyclonal to Hsp70
and rabbit polyclonal to iNOS. All antibodies were purchased from
Abcam Company. The secondary antibody was HRP-conjugated
goat anti-rabbit or mouse antibody. The immunolabelling wases. H9c2, HL-1 and HCM cells were exposed to normoxic (20% O2), or hypoxic (10%
200 lM) as well as re-oxygen conditions. (A) Western blotting was performed to
performed using speciﬁc miR-21 primers to analyze the expression of miR-21. U6
xperiments. Error bar represented the sd of the mean in triplicate. ⁄P < 0.05.
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the manufacturer’s instructions.
2.3. Quantitative reverse transcription polymerase chain reaction
(qRT-PCR)
Total RNAs were extracted from the cells under normoxic or
hypoxic conditions using Trizol agent (Invitrogen) according to
the manufacturer’s protocols. The quality and quantity of RNAs
was measured using NanoDrop ND-2000 spectrophotometer.
500 ng of RNA was then reverse transcribed using miR-21 speciﬁc
primers. U6 snRNA was used as an internal control to normalize
miR-21 expression. The primers for miR-21 and U6 snRNA reverse
transcription were: miR-21: 50 CGTCGCTACGAGTGTAGCATATGFig. 2. Silencing of HIF-1a increases cell apoptosis and decreases the expression of HIF-1a
against HIF-1a or the scrambled control were subjected to Western blotting to analyze th
cell apoptosis was determined using a TUNEL assay kit. The image showed the nucleus (b
and HL-1 cells were exposed to normoxic or hypoxic conditions. Then cell lysates were co
4, HSP70, i-NOS and VEGF-B. GAPDH served as a loading control.CGACGTCAACATC 30; U6: 50 AAAATATGGAACGCTTCACGAATTTG
30. qRT-PCR was performed using speciﬁc miR-21 primers on a
7900HT Fast Real-Time System (Applied Biosystems) according to
the manufacturer’s instructions. miR-21 forward primer: 50 TGTC
GGGTAGCTTATCAGAC 30; miR-21 reverse primer: 50 TTCAGACAG
CCCATCGACTG 30. U6 snRNA forward primer: 50 CTCGCTTCGGCAG
CACATATACT 30; U6 snRNA reverse primer: 50 ACGCTTCACGAATTT
GCGTGTC 30.
2.4. RNA interference
To knockdown HIF-1a expression, the synthesized siRNA oligo-
nucleotides against HIF-1awere transfected in cells, along with the
scrambled oligonucleotides. After transfection for 48 h, the cells0 downstream genes under hypoxia. (A) H9c2 and HL-1 cells transfected with siRNA
e expression of HIF-1a. GAPDH served as a loading control. (B) After transfection, the
lue) and the apoptotic cells (green) at 20 magniﬁcation. (C) The transfected H9c2
llected for Western blotting to analyze the expression of HIF-1a0 target genes GLUT-
3140 Y. Liu et al. / FEBS Letters 588 (2014) 3137–3146were harvested and subjected to Western blotting to analyze HIF-
1a expression. GAPDH was used as an internal control.
2.5. TUNEL assay
Cell apoptosis was determined by In situ Cell Death Detection
Kit (Roche) based on labeling of DNA strand breaks (TUNEL tech-
nology). Brieﬂy, the transfected cells were seeded into 14-well
slides at a density of 4000 cells/slide. After 24 h, the cells were
washed with PBS followed by being ﬁxed with 4% paraformalde-
hydein in PBS for 1 h at 25 C. Then the slides were rinsed with
PBS and subsequently incubated in 0.1% Triton X-100 in 0.1%
sodium citrate for 2 min on ice. The slides were again rinsed with
PBS. When the area around the samples were dried, 50 ll of TUNEL
reaction mixture was added on samples and the slides were incu-
bated in a humidiﬁed atmosphere for 1 h at 37 C in the dark.
Finally, the slides were washed with PBS and the samples were
directly analyzed under a ﬂuorescence microscope.
2.6. Luciferase assay
Human miR-21 promoter was predicted using Promoter 2.0
prediction server and was then ampliﬁed by PCR from genomic
DNA of HCM cells. PCR products were digested and inserted into
pGL4.10 vector (luc2; Promega). Mutation within HIF-1a and
miR-21 binding sites was generated using a QuikChange site-
directed mutagenesis kit (Stratagene) according to the manufac-
turer’s recommendations (Invitrogen). The pTK-luc (Renilla) vector
was cotransfected with the pGL4.10 constructs and used as aFig. 3. Silencing of HIF-1a reduces miR-21 expression and increases the expression
of miR-210 target genes under hypoxia. H9c2 and HL-1 cells were transfected with
siRNA against HIF-1a or the scrambled control under hypoxic and normoxic
conditions. (A) qRT-PCR was performed using speciﬁc miR-21 primers to analyze
miR-21 expression. U6 snRNA served as an internal control. Each value was the
average of three independent experiments. Error bar represented the sd of the mean
in triplicate.⁄P < 0.05. (B) Western blotting was performed to analyze the expression
of PTEN and Bcl-2. GAPDH served as a loading control.spiked-in control to normalize the transfection efﬁciency. After
transfection for 48 h, the promoter activity was measured using a
Dual-Glo™ Luciferase Assay System (Promega) according to the
manufacturer’s protocol.
2.7. Chromatin Immunoprecipitation (ChIP) assay
The experiment was performed using a ChIP assay kit
(Beyotime) as previously described [21]. Brieﬂy, cells were rinsed
twice with PBS and cross-linked using 1% formaldehyde in PBS
for 10 min at room temperature. The reactions were quenched
with 125 mM glycine for 5 min. Cells were rinsed twice with PBS
followed by centrifugation at 1500 rpm at 4 C for 10 min. The pel-
lets were lysed with lysis buffer supplemented with protease
inhibitors for 10 min on ice. The cell lysates were sonicated into
chromatin fragments between 200 bp and 1 kb, followed by centri-
fugation at 12,000 rpm at 4 C for 5 min. The supernatant was
diluted in ChIP dilution buffer with 1 mM PMSF, followed by addi-
tion of Protein A + G agarose/Salmon Sperm DNA. Then the samples
were centrifuged at 1000 rpm at 4 C for 1 min, and the superna-
tant was immunoprecipitated overnight at 4 C using anti-HIF-1a
antibody. Samples with anti-actin antibody were used as negative
controls. Immunocomplexes were recovered by addition of Protein
A + G agarose/Salmon Sperm DNA followed by centrifugation at
1000 rpm at 4 C for 1 min. The immunoprecipitated DNA was
retrieved from the beads by incubation in elution buffer at 65 C
for 4 h. For analysis of HIF-1a binding to the promoter of miR-21,
PCRs were performed with the primers that spanned the region
of HIF-1a binding sites in the promoter of miR-21. The primers
were CTGAGGCAAAGGGAAATG (forward); GAGACCAGCCTGGCTA
ACAC (reverse). PCR products were analyzed on a 1.5% agarose
gel by ethidium bromide staining.
2.8. Endogenous immunoprecipitation (Co-IP) analysis
The transfected H9c2 and HCM cells were harvested by rinsing
with PBS and lysed with IP buffer (50 mM Tris–HCl, pH 8, 150 mM
NaCl, 0.5% NP-40, 0.5% sodium deoxycholate and protease inhibitor
cocktail) as previously described [23]. Brieﬂy, 500 lg of proteins
was incubated with anti-CBP/p300 antibody. The immunocomplex
were incubated overnight on a rotator at 4 C, followed by addition
of protein A + G agarose beads for 2 h. After washed and eluted, the
protein samples were used for Western blotting as described
above. During the Western blotting, antibodies against HIF-1a
and IgG were used.
2.9. Statistical analysis
All data were presented as mean ± standard deviation (sd) from
three independent experiments, and each group was tested in trip-
licate. The difference was analyzed using a Student’s t-test and
P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. HIF-1a and miR-21 are induced by hypoxia in cardiomyocytes
To investigate the roles of HIF-1a and miR-21 in response to
hypoxia in cardiomyocytes, we tried to compare the expression
of HIF-1a and miR-21 under normoxic (20% O2) and hypoxic con-
ditions (10% or 2% O2) as well as hypoxia mimetic condition
(50 lM or 200 lM CoCl2). As shown in Fig. 1A, we found that low
oxygen induced HIF-1a expression, while re-oxygen reduced the
HIF-1a expression induced by hypoxia. In line with the hypoxic
condition, CoCl2 increased HIF-1a expression in a dose-dependent
manner. The results were similar in cardiomyocyte cell lines H9c2,
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indicative of hypoxia. Given that miR-21 was upregulated by
hypoxia in cancer [21], we preformed qRT-PCR to analyze the effect
of hypoxia on miR-21 expression in cardiomyocytes. We found that
miR-21 was also induced by hypoxia as well as CoCl2 treatment,
same as that of HIF-1a expression (Fig. 1B).
3.2. Silencing of HIF-1a increases cell apoptosis and inhibits its
downstream target genes under hypoxia
Next, we investigate the roles of HIF-1a in cardiomyocytes
apoptosis under hypoxia. H9c2 and HL-1 cells were transfected
with siRNA against HIF-1a or scrambled control. The expression
of HIF-1a under hypoxia was conﬁrmed by Western blotting, com-
pared with that under normoxic condition (Fig. 2A). TUNEL analy-
sis showed that silencing of HIF-1a increased H9c2 cell apoptosis,
and similar results were observed in HL-1 cells (Fig. 2B). Then sev-
eral downstream target genes of HIF-1a were tested under
hypoxia. We found that HIF-1a knockdown resulted in a decrease
in the expression of Glut-4, VEGF-B, iNOS and HSP70 (Fig. 2C).
These data imply that HIF-1a may exert a protective role in
response to hypoxia in cardiomyocytes.
3.3. HIF-1a modulates the expression of miR-21 and its target genes
Given that miR-21 is upregulated by HIF-1a under hypoxia in
cancer [21], we aimed to detect whether HIF-1a affected miR-21
expression in hypoxic cardiomyocytes. Results from qRT-PCR anal-
ysis demonstrated that silencing of HIF-1a resulted in a decrease in
miR-21 expression (Fig. 3A). In addition, we also determined the
effect of HIF-1a on the expression of miR-21’ targets phosphataseFig. 4. miR-21 is a transcriptional target of HIF-1a. (A) Schematic representation of putat
exposed to normoxic (20% O2) or hypoxic (10% and 2% O2) conditions and harvested for
1aantibody. Anti-IgG antibody was used as a negative control. (B) Schematic representat
the binding sites. The regions either containing the wild-type or mutated binding sites w
transfected with the above reporter-vector constructs and exposed to normoxic (20%
determined at the indicated time, and renilla expression vector was transfected together
HIF-1a or the scrambled control, and 24 h later the cells were transfected with the report
HIF-1awas conﬁrmed byWestern blotting in the upper panel. Relative ﬁreﬂy luciferase w
spiked-in control. Each value was the average of three independent experiments. Errorand tensin homolog (PTEN) [24] and Bcl-2 [25]. As shown in
Fig. 3B, silencing of HIF-1a increased the expression of PTEN and
Bcl-2 under hypoxia. Taken together, the results show that HIF-
1a increased miR-21 expression under hypoxia, and also modu-
lated the expression of PTEN and Bcl-2.
3.4. miR-21 is a transcriptional target of HIF-1a
Considering that HIF-1a is a transcription factor, we aimed to
investigate whether the regulation of miR-21 by HIF-1a under
hypoxia occurred at the transcriptional level. To this end, we ana-
lyzed the promoter region of miR-21 and found that there were
two putative HIF-1a consensus binding sites (Fig. 4A and B).
H9c2 and HCM cells were exposed to normoxic or hypoxic condi-
tions and the binding of HIF-1a to miR-21 promoter was analyzed
using a ChIP assay. The results demonstrated that protein/DNA
complexes immunoprecipitated with anti-HIF-1a antibody
resulted in a speciﬁc PCR product ﬂanking the region of binding
sites 1 under hypoxia. However, the binding of HIF-1a to binding
sites 2 was not detectable (Fig. 4 A). We then tested the effect of
hypoxia on the miR-21 promoter activity. The miR-21 promoter
either containing the wild type or mutated binding sites was fused
to a luciferase reporter vector as shown in Fig. 4B, and the pro-
moter activity was performed under normoxic and hypoxic condi-
tions. Results from luciferase assay indicated that the activity of a
luciferase reporter fused to either a wild type promoter or a
mutated promoter with mutation within HIF-1a binding sites 2,
not that of a luciferase reporter fused to a mutated promoter with
mutation within HIF-1a binding sites 1, was increased signiﬁcantly
under hypoxia (Fig. 4C). The results were similar in H9c2 and HCMive HIF-1a binding sites in the promoter region of miR-21. H9c2 and HCM cells were
ChIP analysis. Chromatin-bound DNA was immunoprecipitated with the anti-HIF-
ion of HIF-1a binding sites in miR-21 promoter and mutation was generated within
ere cloned upstream of the luciferase coding region. (C) H9c2 and HCM cells were
O2), or hypoxic (10% and 2% O2) conditions. The activity of ﬁreﬂy luciferase was
as a spiked-in control. (D) H9c2 and HCM cells were transfected with siRNA against
er-vector constructs involving the wild-type HIF-1a binding sites. The expression of
as shown in the lower panel. Renilla expressing vector was transfected together as a
bar represented the sd of the mean in triplicate. ⁄P < 0.05.
Fig. 5. CBP/p300 is essential for the binding of HIF-1a to miR-21 promoter via interacting with HIF-1a. (A) H9c2 and HCM cells were transfected with siRNA against CBP/p300
or the scrambled control under hypoxic condition (2% O2). Endogenous immunoprecipitation assay was performed to detect the interaction between CBP/p300 and HIF-1a.
The cell extracts were immunoprecipitated with anti-CBP/p300 antibody. The silencing of CBP/p300 was conﬁrmed byWestern blotting (upper panel). The presence of HIF-1a
in immunoprecipitates was detected using anti-HIF-1a antibody by Western blotting (lower panel). (B) H9c2 and HCM cells were transfected with siRNA against CBP/p300 or
the scrambled control, and 24 h later the cells were transfected with the reporter-vector constructs involving the wild-type HIF-1a binding sites under hypoxia. Relative
ﬁreﬂy luciferase was shown in the graph. Renilla expressing vector was transfected together as a spiked-in control. (C) H9c2 and HCM cells were transfected with siRNA
against CBP/p300 or the scrambled control under hypoxic condition (2% O2). The protein was extracted and the silencing of CBP/p300 was conﬁrmed by Western blotting
(upper panel). Histone H3 was used as an internal control for nuclear proteins. ChIP assay was performed in control and CBP/p300 silenced cells. Silencing of CBP/p300
suppressed the binding of HIF-1a to miR-21 promoter. IgG was used as a negative control. Each value was the average of three independent experiments. Error bar
represented the sd of the mean in triplicate. ⁄P < 0.05.
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promoter activity under hypoxia. H9c2 and HCM cells were co-
transfected with miR-21 promoter plasmid and siRNA against
HIF-1a under hypoxia, together with the controls. Luciferase assay
indicated that the activity of miR-21 promoter was reduced in cells
upon silencing of HIF-1a under hypoxia (Fig. 4D). Overall, these
results suggest that HIF-1a increased miR-21 expression via direct
binding to the binding sites 1 on miR-21 promoter.
3.5. CBP/p300 is essential for the binding of HIF-1a to miR-21
promoter via interacting with HIF-1a under hypoxia
It is reported that HIF-1a activation needs the modulation of its
transactivation domains, which functions by recruiting transcrip-
tional coactivators such as CBP/p300 [26]. Therefore, we testedwhether the regulation of miR-21 by HIF-1a required the recruit-
ment of CBP/p300 in hypoxic cardiomyocytes. H9c2 and HCM cells
were transfected with siRNA against CBP/p300 under hypoxia and
the interaction between HIF-1a and CBP/p300 was analyzed using
a Co-IP assay. The expression of CBP/p300 was conﬁrmed by
Western blotting (Fig. 5A). Co-IP assay indicated that protein–pro-
tein complexes precipitated with CBP/p300 resulted in a decrease
in the expression of HIF-1a upon silencing of CBP/p300 in hypoxic
H9c2 cells. The similar results were observed in HCM cells (Fig. 5A).
We then investigated the effect of CBP/p300 on miR-21 promoter
activity under hypoxia in H9c2 and HCM cells. Luciferase assay
demonstrated that the activity of miR-21 promoter was reduced
in the cells with low levels of CBP/p300, compared with the cells
with scrambled siRNA control (Fig. 5B). Finally, we determined
whether CBP/p300 is essential for the binding of HIF-1a to
Fig. 6. Inhibition of miR-21 promotes cell apoptosis and reduces HIF-1a expression under hypoxia. H9c2 and HCM cells transfected with miR-21 ASO or ASO control were
exposed to normoxic (20% O2), or hypoxic (10% and 2% O2) conditions. (A) Total RNA was extracted and qRT-PCR was performed to detect the expression of miR-21. U6 snRNA
served as an internal control. Each value was the average of three independent experiments. Error bar represented the sd of the mean in triplicate. ⁄⁄⁄P < 0.001. (B) Cell
apoptosis was determined using a TUNEL assay kit. The image showed the nucleus (blue) and the apoptotic cells (green) at 20magniﬁcation. (C) Cell lysates were harvested
and Western blotting was performed to analyze the expression of HIF-1a. GAPDH served as a loading control.
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the association of HIF-1awith miR-21 promoter in the cells treated
with siRNA against CBP/p300 under hypoxia (Fig. 5C). Taken
together, these data suggest that the binding of HIF-1a to miR-21
promoter requires the recruitment of CBP/p300, which interacts
with HIF-1a.
3.6. Inhibition of miR-21 promotes cell apoptosis and reduces HIF-1a
expression under hypoxia
Since the above data showed that HIF-1a upregulated miR-21
expression and modulated cell apoptosis, we tried to test the effect
of miR-21 on cell apoptosis in cardiomyocytes under hypoxia.
H9c2 and HCM cells transfected with miR-21 ASO or control were
exposed to normoxic (20% O2) and hypoxic conditions (10% or 2%
O2) conditions. qRT-PCR assay showed that miR-21 expression
was signiﬁcantly reduced in the cells with miR-21 ASO under
hypoxia, compared with the cells with ASO control (Fig. 6A). The
results from TUNEL assay indicated that inhibition of miR-21
resulted in an increase in cell apoptosis under hypoxia (Fig. 6A),
which phenocopied the roles of HIF-1a knockdown. Based on the
study that miR-21 can increase HIF-1a expression [22], we
assessed the impact of miR-21 on the expression of HIF-1a in hyp-
oxic H9c2 and HCM cells. As shown in Fig. 6B, we found that miR-
21 inhibition resulted in a decrease in HIF-1a expression under
hypoxia.
3.7. miR-21 regulates PTEN, Bcl-2 and Akt pathway under hypoxia
PTEN and Bcl-2 are well-known targets of miR-21 as previously
validated. In our study, we investigated the roles of miR-21 on the
expression of PTEN and Bcl-2 under hypoxia in cardiomyocytes.
We found that inhibition of miR-21 resulted in an increase in the
expression of PTEN and Bcl-2 in hypoxic H9c2 and HCM cells
(Fig. 7A). We then investigate its downstream signaling pathway.
The phospho-Akt and Akt were tested in the cells transfected with
miR-21 ASO or ASO controls under hypoxia and normoxia. We
found that the activation of phospho-Akt was reduced upon miR-
21 inhibition under hypoxia (Fig. 7B).4. Discussion
Myocardial ischemia is manifested by localized hypoxia. Studies
have shown that the central in response to hypoxia is the induction
of transcription factor HIF-1a. In line with the data in the reported
studies, in the current study, we found that HIF-1awas induced by
hypoxia (10% or 2% O2), but little detectable under normoxia (20%
O2). Using CoCl2 imitates the hypoxia mimetic treatment, we found
that HIF-1a expression increased in a dose-dependent manner
upon CoCl2 treatment. We then discovered that HIF-1a knockdown
suppressed the apoptosis of hypoxic cardiomyocytes, indicating
that HIF-1a plays a protective role in cardiomyocytes under
hypoxia and it has potential as therapeutic target for myocardium
ischemia. Accordingly, a study have validated that stabilization of
HIF-1 by using a selective HIF-PHD inhibitor improves long-term
ventricular function, remodeling and vascularity in chronic
post-myocardial infarction [27]. Chen et al. indicates that plas-
mid-mediated HIF-1a therapy for myocardial ischemia should be
a prospective strategy, which will be monitored using a non-
invasive technique [28]. Besides the potential application of HIF-
1a in improving myocardial ischemia, it also plays protective roles
in ameliorating postishemic renal injury [9].
When cells are subjected to hypoxia, upregulation of angiogenic
growth factor VEGF by HIF-1a results in an increased blood ﬂow
and oxygen supply, reducing the harmful impact of ischemia
[29]. In the in vivo study, overexpression of HIF-1a induced the
expression of VEGF [30]. miR-21 has been validated to induce angi-
ogenesis via the upregulation of VEGF by HIF-1a [22]. HIF-1a acti-
vates VEGF via the hypoxia response element (HRE) on the VEGF
promoter [31]. In agreement with the data in the previous studies,
our results showed that HIF-1a knockdown decreased the expres-
sion of VEGF-B under hypoxia. Besides the induction of VEGF, other
downstream targets are induced by HIF-1a to enable cells to adapt
to hypoxic conditions. When cardiac myocytes are subjected to
hypoxia, iNOS expression is overexpressed via the direct regulation
by HIF-1a [32]. Similar data has been shown in response to
hypoxia in ischemia renal injury [9]. Hsp70 is also upregulated
by HIF-1a under hypoxic condition in chondrocytes, and they
increased cell viability and suppresses cell apoptosis, contributing
3144 Y. Liu et al. / FEBS Letters 588 (2014) 3137–3146the adaption of cells to hypoxia [33]. In addition, the GLUT-4
protein that performs glucose uptake is also upregulation by HIF-
1a to improve glycemic homeostasis via the binding of HIF-1a to
its promoter [7]. Consistent with the data, we found that HIF-1a
downregulated the expression of VEGF-B, GLUT-4 and iNOS under
hypoxia in cardiomyocytes, implying that these proteins may par-
ticipate in the adaptation of cardiac myocytes to hypoxia via HIF-
1a regulation.
Recent studies revealed that miRNAs were associated with key
signaling pathways and played important roles in the adaptation of
cells to hypoxia. miRNAs, such as miR-210 and miR-155, are upreg-
ulated by HIF-1a under hypoxia by which HIF-1a binds to their
promoter [34,35]. HIF-1a can also regulate miRNA expression via
the modulation of their transcription factors [36]. In our study,
we found that HIF-1a knockdown reduced miR-21 expression.
The binding of HIF-1a to miR-21 promoter was tested using a ChIP
assay. The results showed that HIF-1a bound to the binding sites 1
on miR-21 promoter, but the association of HIF-1a with binding
sites 2 was not detectable under hypoxia. We then detected the
effect of HIF-1a on miR-21 promoter activity under hypoxia. We
cloned the miR-21 promoter containing the binding sites 1 and 2
into the luciferase reporter vector, and the mutations wereFig. 7. miR-21 regulates PTEN, Bcl-2 and Akt pathway under hypoxia. H9c2 and HCM cell
hypoxic (10% and 2% O2) conditions. Western blotting was performed to analyze the expre
GAPDH served as a loading control. (C) Proposed model of HIF-1a-miR-21 feedback u
relationship, and their roles in response to cell apoptosis under hypoxia in cardiomyocygenerated within each binding sites. When the cells were only sub-
jected to hypoxia or normoxia, the activity of wild type luciferase-
reporter constructs and the luciferase reporter fused to mutated
binding sites 2 increased under hypoxia, but not the reporter fused
to mutated binding sites 1. Combination with the ChIP assay, all
data indicate that HIF-1a binding site 1 is essential for the regula-
tion of miR-21 by HIF-1a. When HIF-1a was knockdown using a
siRNA against HIF-1a, we found that miR-21 promoter activity
was reduced signiﬁcantly under hypoxia, indicating that HIF-1a
in a key regulator of miR-21 expression in response to hypoxia,
via the binding sites 1 on miR-21 promoter. We discovered that
inhibition of miR-21 resulted in an increase in cell apoptosis under
hypoxia, similar to the roles of HIF-1a knockdown. These data fur-
ther investigate that HIF-1a suppresses cell apoptosis under
hypoxia, at least in part, via the upregulation of miR-21.
CBP/p300 is an important transcriptional coactivator that is
required for the transcription activity of HIF-1a, by being recruited
to the promoter of HIF-1a downstream target genes, subsequently
regulating the gene expression [37]. Accordingly, our results
showed that CBP/p300 interacted with HIF-1a under hypoxia,
and silencing of CBP/p300 reduced the miR-21 promoter activity.
When CBP/p300 was knockdown, the binding of HIF-1a tos transfected with miR-21 ASO or ASO control were exposed to normoxic (20% O2), or
ssion of PTEN and Bcl-2 (A), as well as the phosphorylation level of Akt pathway (B).
nder hypoxia in cardiomyocytes. Schematic representation of HIF-1a and miR-21
tes.
Y. Liu et al. / FEBS Letters 588 (2014) 3137–3146 3145miR-21 promoter was reduced. These data conﬁrm that CBP/p300
is essential for the binding of HIF-1a to miR-21 promoter.
Our data validated that HIF-1a upregulated miR-21 expression,
in turn, miR-21 affected HIF-1a expression. We then investigated
the mechanism by which miR-21 upregulated HIF-1a under
hypoxia. Studies have indicated that PTEN is a downstream target
of miR-21 and suppressed by miR-21 [24]. PTEN is a suppressor of
PI3K/Akt pathway by removing the 30phosphate of PIP3, resulting
in the inactivation of the phosphorylation of PI3K/Akt signaling
pathway [38–40]. In line with the ﬁndings in the previous studies,
our study showed that inhibition of miR-21 increased the expres-
sion of PTEN, and reduced the phosphorylation levels of Akt under
hypoxia. Importantly, studies indicate that HIF-1a is a downstream
target of PTEN/PI3K/Akt signaling pathway involved in tumorigen-
esis as well as in response to hypoxia [41,42]. microRNA-494 up-
regulates HIF-1a expression via PI3K/Akt pathway and protects
against hypoxia-induced apoptosis [43]. Ascofuranone suppresses
EGF-induced HIF-1a expression by inhibiting the Akt/mTOR/
p70S6K pathway in breast cancer cells [44]. These data suggest
that miR-21 might modulate HIF-1a expression via the regulation
of PTEN/Akt pathway.
In summary, our data show that hypoxia induced HIF-1aand
miR-21 expression. HIF-1a transcriptionally increased miR-21
expression via the direct binding sites on miR-21 promoter. miR-
21 upregulated HIF-1a expression, at least in part, via the regula-
tion of PTEN/Akt signaling pathway (Fig. 7C). The HIF-1a-miR-21
feedback plays an important role in the suppression of cell apopto-
sis under hypoxia, implying that HIF-1a-miR-21 feedback has
potential as therapeutic strategy for cardiac ischemia or hypoxia.Conﬁct of interest
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